OVERVIEW

A Weight Loss Journey in Primary Care: Integrating Obesity Medication Into Treatment Plans is organized by Med-IQ.

Released: 3/13/2025
Expires: 3/12/2026

Abstract
By making real-time decisions and seeing the consequences in interactive, realistic case scenarios, you'll solidify your knowledge, hone critical thinking, and gain invaluable experience in a safe, simulated setting. Prepare for real-world patient care with practice and expert feedback.

Here are the key takeaways from this activity. Deeper insights and evidence, plus an opportunity to receive credit, are available.

Obesity is a complex, chronic disease that currently affects approximately 40% of adults in the United States and is projected to affect 50% by 2030
Obesity is associated with an increased risk of cardiovascular-related mortality, as well as several other comorbidities
Despite the recognized influence of genetic, socioeconomic, and environmental factors in the development of obesity, this complex disease continues to be wrongly associated with laziness, irresponsibility, and a lack of self-discipline
Using nonstigmatizing, person-first language (eg, “person with obesity” rather than “obese person”) is crucial for achieving patient-centered care, enhancing the patient-provider relationship, and encouraging patients to seek the care they need
Current practice guidelines define obesity management as a comprehensive, individualized approach focused on preventing and treating weight-related complications
Lifestyle modifications are a fundamental component of obesity management
As an adjunct to lifestyle modifications, obesity medications are approved for use in individuals with a BMI of at least 30 kg/m² or at least 27 kg/m² with a weight-related comorbidity
Additional studies demonstrate that obesity pharmacotherapy combined with lifestyle intervention yields 3% to 9% greater weight reduction than lifestyle intervention alone
Evidence-based strategies for optimizing treatment adherence include structured shared decision making and comprehensive patient education regarding obesity chronicity

Learning Objectives:
Upon completion, participants should be able to:

Use respectful and nonstigmatizing language with patients who have obesity when discussing their weight and their weight loss journey
Determine evidence-based, safe, and effective pharmacologic strategies for weight loss and maintenance in patients with obesity

Statement of Need:
Obesity currently affects more than 41% of adults in the United States. It is a complex and chronic medical condition that is often associated with reduced quality of life in the absence of appropriate care and the development of diabetes, hypertension, cardiovascular disease, and other comorbidities. Once considered a condition caused by poor eating habits and lack of self-control or will power, obesity is now recognized as a disease that calls for long-term medical management and often requires pharmacotherapeutic intervention for adequate weight control.

Most patients are unlikely to initiate conversations about obesity and weight reduction with their healthcare provider and often look to their healthcare provider to begin these difficult discussions. In addition, even though obesity pharmacotherapy is largely advertised and has recently become prevalent among the general public, few patients with obesity are offered obesity medications or even appropriately diagnosed, counseled about the benefits of healthy weight, referred for weight loss services, or offered surgical consults. Lifestyle changes, such as dietary or nutritional measures, exercise, and physical activity, are the first-line treatments for obesity. However, lifestyle changes alone are often inadequate for patients to lose weight or maintain their weight loss, even among those who are vigilant in making significant and sustained changes. These difficulties highlight the importance of general practitioners getting involved in and initiating long-term treatment of obesity.

Clinical practice guidelines recommend that primary care clinicians support and engage patients in individualized obesity management plans, but significant time constraints and limited knowledge of and training in obesity medicine contribute to the reported underuse of lifestyle counseling, pharmacotherapy, and bariatric surgery referrals. Clinicians also need to stay updated on the evolving landscape of obesity medications to optimize treatment according to patient-specific factors, educate patients about and monitor for potential concerns, and incorporate shared decision making to achieve the best possible patient outcomes.